Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

NCT07654361 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

3600

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Chronic Weight Management

Interventions

DRUG: Aleniglipron
DRUG: Placebo

Sponsor

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics